This is often: A BMI of 30 or above for obesity A BMI of 27 or above for overweight if there is at least one weight-related health condition Weight-related conditions can include high blood pressure, raised cholesterol, prediabetes, type 2 diabetes or sleep apnoea
For clinicians, researchers, and industry professionals whose work intersects with metabolic health, it is now more essential than ever to understand the physiology, pharmacology, and evidence behind these game-changing therapies
Blood Pressure Changes During GLP-1 Treatment Many patients report elevated heart rate or temporary blood pressure spikes during the first 24 weeks of starting semaglutide, a phenomenon sometimes called 'GLP-1 adjustment.' This occurs because the medication's effect on metabolic rate can temporarily increase sympathetic nervous system activity
Failure at this stage can result in bacterial contamination
1) conducted using US claims data from the Merative MarketScan Commercial and Medicare Databases